Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 986 | 919 | 994 | 1413 | 1374 | 2040 |
Fund Return | -1.43% | -8.08% | -0.63% | 12.22% | 6.57% | 7.39% |
Place in category | 228 | 106 | 236 | 141 | 137 | 75 |
% in Category | 50 | 19 | 52 | 33 | 42 | 37 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Robeco BP US Premium Equities F $ | 5.29B | 8.63 | 9.51 | 9.42 | ||
Robeco BP US Premium Equities I $ | 5.29B | 4.06 | 10.16 | 9.34 | ||
Robeco BP US Premium Equities K $ | 5.29B | 4.06 | 10.16 | 9.34 | ||
R BP Global Premium Equities Du | 4.58B | 2.03 | 7.87 | 6.48 | ||
R BP Global Premium Equities Iu | 4.58B | 2.14 | 8.58 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Robeco BP US Premium Equities F $ | 5.29B | 8.63 | 9.51 | 9.42 | ||
Robeco BP US Premium Equities I $ | 5.29B | 4.06 | 10.16 | 9.34 | ||
Robeco BP US Premium Equities K $ | 5.29B | 4.06 | 10.16 | 9.34 | ||
LU2216803838 | 5.29B | -0.62 | 13.32 | - | ||
JPMorgan US Value X Acc USD | 3.25B | 10.57 | 10.80 | 9.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
J&J | US4781601046 | 2.55 | 154.31 | +0.02% | |
Bristol-Myers Squibb | US1101221083 | 2.24 | 44.05 | -0.12% | |
Alphabet A | US02079K3059 | 2.04 | 175.40 | +0.70% | |
AbbVie | US00287Y1091 | 1.91 | 166.06 | +1.04% | |
Sanofi ADR | US80105N1054 | 1.83 | 48.50 | -0.65% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review